More Akeso, Inc. news
Akeso, Inc.HKEX: 9926

Next Day Disclosure Return

Oct 16, 2026 at 4:41 AM EDT · Issued by Akeso, Inc. via HKEXnews

Filed with HKEX · Stock code 9926 · Oct 16, 2026 at 4:41 AM EDT · 6 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-return-1168

Akeso, Inc. on 6ix

Earlier from Akeso

  • Completion of placing of new shares under general mandateOct 16
  • Placing of new shares under general mandateOct 13
  • Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026Oct 7
  • 2026 Interim reportSep 30
  • Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric CancerSep 27

Later from Akeso

  • Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with CadonilimabOct 19
All Akeso news releases↗

Follow Akeso into a list and get an email when it puts out news.

Follow Akeso
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer